Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irina A. Favorskaya
Observed names:
Favorskaya I.A.,
I Favorskaya,
I. A. FAVORSKAYA,
I. A. Favorskaya,
I.A. Favorskaya,
Irina A Favorskaya,
Irina Favorskaya
show all 7
Institutions:
Gamalei Institute of Epidemiology and Microbiology,
Ministry of Health of the Russian Federation
Observed institutions:
N.D. Zelinsky Institute of Organic Chemistry,
Russian Cancer Research Center NN Blokhin,
Gamalei Institute of Epidemiology and Microbiology,
Ministry of Health of the Russian Federation
ORCID:
0000-0003-0639-8390
Observed ORCID:
0000-0003-0639-8390
OpenAlex ID:
A5062273340
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
2021
·
Denis Y Logunov
, Inna V Dolzhikova
, et al.
·
The Lancet
·
1,916
PDF
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
2020
·
Denis Y Logunov
, Inna V Dolzhikova
, et al.
·
The Lancet
·
1,144
PDF
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
2021
·
Amir I. Tukhvatulin
, Inna V. Dolzhikova
, et al.
·
The Lancet Regional Health - Europe
·
77
Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer
2014
·
Irina Favorskaya
, Yaroslav Kainov
, et al.
·
Tumor Biology
·
44
CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors
2014
·
Yaroslav Kainov
, Irina Favorskaya
, et al.
·
Cell Cycle
·
39
PDF
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
2022
·
Irina A. Favorskaya
, Dmitry V. Shcheblyakov
, et al.
·
Frontiers in Immunology
·
38
PDF
Abnormal expression of genes that regulate retinoid metabolism and signaling in non-small-cell lung cancer
2016
·
E. S. Kuznetsova
, O. L. Zinovieva
, et al.
·
Molecular Biology
·
31
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
2022
·
Daria V. Voronina
, Dmitry V. Shcheblyakov
, et al.
·
Viruses
·
23
PDF
Аномальная экспрессия генов, регулирующих метаболизм и сигнальный путь ретиноидов, при немелкоклеточном раке легкого
2016
·
Е. С. Кузнецова
, О. Л. Зиновьева
, et al.
·
Molecular Biology
·
21
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
2023
·
Ilias B. Esmagambetov
, Ekaterina I. Ryabova
, et al.
·
Frontiers in Immunology
·
17
PDF
Expression profiling and putative mechanisms of resistance to doxorubicin of human lung cancer cells
2010
·
K. N. Kashkin
, E. A. Musatkina
, et al.
·
Doklady Biochemistry and Biophysics
·
17
Genes potentially associated with Cisplatin resistance of lung cancer cells
2011
·
K. N. Kashkin
, E. A. Musatkina
, et al.
·
Doklady Biochemistry and Biophysics
·
13
Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus
2024
·
D. V. Shcheblyakov
, D. V. Voronina
, et al.
·
Acta Naturae
·
8
CRABP proteins – relatives or homonyms?
2015
·
E. M. Tchevkina
, I. A. Favorskaya
·
Advances in molecular oncology
·
6
PDF
Ultra-potent RBM-specific single-domain antibody broadly neutralizes multiple SARS-CoV-2 variants with picomolar activity
2025
·
Dmitry V. Shcheblyakov
, Irina A. Favorskaya
, et al.
·
International Journal of Biological Macromolecules
·
5
Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain
2024
·
Nikolai N. Sluchanko
, Dmitry V. Shcheblyakov
, et al.
·
Biochemistry (Moscow)
·
5
PDF
Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents
2026
·
Inna V. Shuliakova
, Daria M. Grousova
, et al.
·
Frontiers in Immunology
·
4
PDF
Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice
2025
·
Daria V. Voronina
, Irina V. Vavilova
, et al.
·
Viruses
·
3
PDF
Preparation and Crystallographic Analysis of a Complex of SARS-CoV-2 S-Protein Receptor-Binding Domain with a Virus-Neutralizing Nanoantibody
2023
·
K. M. Boyko
, L. A. Varfolomeeva
, et al.
·
Crystallography Reports
·
3
Structural insight into recognition of Clostridioides difficile toxin A by novel neutralizing nanobodies targeting QTIN-like motifs within its receptor-binding domain
2024
·
Nikolai N. Sluchanko
, Irina V. Sokolova
, et al.
·
International Journal of Biological Macromolecules
·
2
Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies
2023
·
A. A. Derkaev
, E. I. Ryabova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
2
PDF
Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants
2026
·
Anastasia I. Korobkova
, Irina A. Favorskaya
, et al.
·
Frontiers in Immunology
·
1
PDF
ChemInform Abstract: PROTOTROPIC ISOMERIZATION OF ACETYLENIC HYDROCARBONS AND ALCOHOLS IN THE PRESENCE OF LITHIUM 2‐AMINOETHYLAMIDE IN ETHYLENEDIAMINE
1985
·
L. A. REMIZOVA
, A. V. KRYUKOV
, et al.
·
ChemInform
·
1
Isolation of monoclonal neutralizing single-domain antibodies against Clostridioides difficile toxin B
2026
·
I. A. Alekseeva
, A. S. Ungur
, et al.
·
Acta Naturae
PDF
Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates
2026
·
Ekaterina I. Ryabova
, Artem A. Derkaev
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
65
Citation count:
3,420
H-index:
12
I10-index:
12
Year
Topic
Type